News

News
Select Month
IMMUNO-model released Annual report for Grant Period 3, in which activities and achievements of IMMUNO-model are summarized
Date and place: 20-22 May 2026, National Institute of Biology, Ljubljana, Slovenia We are delighted to announce the Final IMMUNO-model Annual Conference – Building Bridges in Cancer Immunotherapy Modelling, where...
Join us for this hybrid international symposium exploring the latest advances in 3D modelling of immunotherapy, from patient-derived organoids and tumour-on-chip platforms to innovative preclinical models that bring research closer to clinical application. This...
Medicinal chemistry of the PD-1/PD-L1 immune checkpoint: where organic chemistry, biochemistry, and immunology meet. Lukasz Skalniak,Associate Professor
ioAVATAR: Immune oncology Drug Discovery & Decision – Advanced ex Vivo Approach To Accelerate Response prediction for combined therapies in ovarian cancer”, is one of the 15 projects funded by...
The symposium ‘MODELS, CHALLENGES AND PROMISES OF ADVANCED THERAPIES FOR CANCER: NK CELLS IN THE CLINIC AND INDUSTRY’, has a waiting list. Please let us know if you do not...
📅 When: February 9th, 2026📍 Where: To be confirmed in Barcelona (ES) Join us for a one-day international symposium exploring the latest advances in 3D modelling of immunotherapy, from patient-derived...
The 3rd IMMUNO-model TGRC Workshop, titled “Young Researchers and Innovators on Immunotherapies: The Future is Now”, took place at IPO Porto, Portugal, on 25 September 2025, in a hybrid format....
Part of Progress in Inflammation Research book series (Springer) We invite submissions to a new book on Imaging Immune Cells, edited by Dr Doreen Lau (IMMUNO-model Working Group 2 Co-Leader,...
Identification of Immunotherapy Biomarkers📅 Date: June 30 – July 2, 2025📍 Location: Faculty of Medicine, University of Coimbra, Azinhaga de Santa Comba – Celas, 3000-548 Coimbra, Portugal Overview The 3rd IMMUNO-model Training School focused...
Bridging Drug Delivery and Tumor Immunology: A Multidisciplinary Approach to Cancer Therapies Ebru Nur AY,Assistant Professor of Dept. of Molecular Biology and GeneticsIstinye University, Istanbul, Türkiye
🚀 Exciting News from working group 4 of IMMUNO-model! 🧬 We’re proud to announce the publication of four comprehensive review articles from Working Group 4, supported by the IMMUNO-model project! These articles explore key advancements in Cancer...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter